Clinical Trials Logo

Fasting clinical trials

View clinical trials related to Fasting.

Filter by:

NCT ID: NCT00968747 Completed - Fasting Clinical Trials

Regulation of FGF21 by Nutritional Challenges

Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how acute nutritional challenges affect levels of several proteins involved in metabolism. These proteins will be measured in blood and fat tissue. This study will have several aims. One aim is to examine the effect of 72 hours of fasting on fibroblast growth factor-21 (FGF-21) levels. Participants will spend 3 days and nights in the Clinical Research Center at the Beth Israel Deaconess Medical Center in Boston, MA. Daily blood samples will be taken. Two fat samples will be taken prior to and at the end of the fast. A subset of participants will also have two MRIs, one prior to and one at the end of the fast. We will study healthy adults and obese adults with liver-biopsy-diagnosed non-alcoholic fatty liver disease (NAFLD). THIS STUDY ARM IS CURRENTLY NOT RECRUITING Another aim is to examine the effect of low-calorie diet on FGF-21 levels. Subjects will follow a hypocaloric diet that will be designed to achieve 3-5% weight loss. We will enroll participants with liver-biopsy-diagnosed non-alcoholic fatty liver disease. Participants will report weekly to the Clinical Research Center at Beth Israel Deaconess Medical Center for weight measurements. Blood will be drawn before and after the weight loss. Participants will also have an MRI before and after the weight loss. THIS ARM IS CURRENTLY NOT RECRUITING Another aim of the study is to examine the effect of acute ingestion of glucose, fructose, and other sugars on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome. THIS ARM IS CURRENTLY RECRUITING

NCT ID: NCT00757094 Completed - Cancer Clinical Trials

Safety and Feasibility of Fasting While Receiving Chemotherapy

Start date: September 2008
Phase: N/A
Study type: Observational

Fasting (refraining from eating and drinking) during the day is safe while receiving chemotherapy.

NCT ID: NCT00556868 Completed - Fasting Clinical Trials

The Influence of Having Breakfast on Cognitive Performance and Mood

Start date: October 2005
Phase: N/A
Study type: Interventional

Breakfast is often labelled the most important meal of the day. Parents and teachers quite often stress its importance for successful learning during the morning hours. With declining numbers of children and especially adolescents eating breakfast regularly, the study examines the influence of breakfast consumption on cognition and mood of high school students.

NCT ID: NCT00476125 Completed - Fasting Clinical Trials

Effects of Dietary Manipulation on Metabolism in Healthy Adults

Start date: March 2008
Phase: N/A
Study type: Interventional

This study will examine the potential changes in the blood levels of a recently discovered metabolic regulator in response to changes in diet in healthy adults. Our hypothesis is that in healthy adults key regulatory factors involved in lipid oxidation will respond to changes in diet, particularly fasting and diet-induced ketosis.

NCT ID: NCT00140231 Active, not recruiting - Fasting Clinical Trials

Role of Leptin in the Neuroendocrine and Immune Response to Fasting

Start date: October 2002
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study will be to determine whether giving leptin (r-metHuLeptin) to a person when he or she is fasting will reverse changes in metabolism, and hormone levels, and immune function associated with fasting, which decreases leptin levels.